Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GTX 011 - GAT Therapeutics

Next Previous
Drug Profile

GTX 011 - GAT Therapeutics

Alternative Names: GTX-011 - GAT Therapeutics; GTX-11

Latest Information Update: 31 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GAT Therapeutics
  • Class Antifibrotics; Hepatoprotectants; Skin disorder therapies; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Idiopathic pulmonary fibrosis; Pulmonary fibrosis
  • Preclinical Hepatic fibrosis; Non-alcoholic steatohepatitis; Systemic scleroderma
  • Research Myelofibrosis

Most Recent Events

  • 07 Sep 2024 Pharmacodynamics data from a preclinical trial in Idiopathic pulmonary fibrosis presented at the 34th Annual Congress of the European Respiratory Society (ESR-2024)
  • 17 May 2024 Pharmacodynamics data from a preclinical study in Pulmonary fibrosis presented at the 120th International Conference of the American Thoracic Society (ATS-2024)
  • 09 Sep 2023 Data from a preclinical study in Pulmonary fibrosis presented at the 33rd Annual Congress of the European Respiratory Society (ERS-2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top